I see that PolyMedix stock has now earned the dreaded "E" suffix that typically means the company has not met its public reporting obligations pursuant to Rule 6530. Is there no end to the drama? Can PolyMedix management ever get their act together and run the company in a businesslike manner? Stay tuned for the next adventure in small cap investing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.